Virology Market By Type (Diagnostics Test, Antiviral Therapeutics, Viral Infection Controlling Techniques, Interferons) , By Application (Skin & Soft Tissues Infections, GI Tract Infections, Sexually Transmitted Diseases, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

September 2024 | 320 pages | ID: VC4ED5B04321EN
Allied Market Research

Abstracts

Virology Market Expected to Garner $4.6 Billion by 2033, Growing at a CAGR of 5.5%

Abstract: The global virology market is expected to grow primarily due to the growing infections due to new pathogen detection & spread. The Asia-Pacific region is predicted to witness profitable growth by 2033.

As per the report published by Research Dive, the global virology market was valued at $2.7 billion in 2023 and is expected to register a revenue of $4.6 billion by 2033 at a CAGR of 5.5% during the forecast period 2024-2033.

Dynamics of the Market

The increasing incidence of emerging infections due to new pathogen detection & spread, rising need for innovative antiviral drugs, vaccines, and diagnostic tools to combat emerging disease, and growing R&D efforts for effective treatments are expected to make the virology market a highly profitable one during the forecast period.

However, according to market analysts, high costs and stringent regulatory approval processes might restrain the growth of the market.

Rapid evolution in diagnostic technologies, like multiplex RT-PCR and microarray analysis, and continued refinement & standardization of new diagnostic technologies present significant opportunities for virology market growth. Moreover, partnerships & collaborations accelerate innovation in virology research and product development.

Key Players of the Market

The major players of the virology market include GlaxoSmithKline plc, Boehringer Ingelheim Corporation, Abbott Laboratories, Merck and Co. Inc., Siemens, Novartis International AG, Johnson & Johnson, Roche, AstraZeneca AB, and Trinity Biotech.

What the Report Covers

In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Product Life Cycles
• Technology Trend Analysis
• Go To Market Strategy
• Market share analysis of players by products/segments
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Criss-cross segment analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• Market share analysis of players at global/region/country level
• SWOT Analysis

Key Market Segments

By Type

• Diagnostics Test
• Antiviral Therapeutics
• Viral Infection Controlling Techniques
• Interferons

By Application

• Skin Soft Tissues Infections
• GI Tract Infections
• Sexually Transmitted Diseases
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• France
• Germany
• Italy
• Spain
• UK
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• South Africa
• Saudi Arabia
• UAE
• Rest of LAMEA
• Key Market Players
• GlaxoSmithKline Plc.
• Abbott Laboratories
• Boehringer Ingelheim Corporation
• Merck and Co. Inc.
• Novartis International Ag
• Siemens
• Johnson & Johnson
• AstraZeneca AB
• Roche
• Trinity Biotech

Contents

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
  1.4.1. Primary Research
  1.4.2. Secondary Research
  1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
  3.2.1. Top Investment Pockets
  3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
  3.3.1. Bargaining Power of Suppliers
  3.3.2. Threat of New Entrants
  3.3.3. Threat of Substitutes
  3.3.4. Competitive Rivalry
  3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
  3.4.1. Drivers
  3.4.2. Restraints
  3.4.3. Opportunities

CHAPTER 4: VIROLOGY MARKET, BY TYPE

4.1. Market Overview
  4.1.1 Market Size and Forecast, By Type
4.2. Diagnostics Test
  4.2.1. Key Market Trends, Growth Factors and Opportunities
  4.2.2. Market Size and Forecast, By Region
  4.2.3. Market Share Analysis, By Country
4.3. Antiviral Therapeutics
  4.3.1. Key Market Trends, Growth Factors and Opportunities
  4.3.2. Market Size and Forecast, By Region
  4.3.3. Market Share Analysis, By Country
4.4. Viral Infection Controlling Techniques
  4.4.1. Key Market Trends, Growth Factors and Opportunities
  4.4.2. Market Size and Forecast, By Region
  4.4.3. Market Share Analysis, By Country
4.5. Interferons
  4.5.1. Key Market Trends, Growth Factors and Opportunities
  4.5.2. Market Size and Forecast, By Region
  4.5.3. Market Share Analysis, By Country

CHAPTER 5: VIROLOGY MARKET, BY APPLICATION

5.1. Market Overview
  5.1.1 Market Size and Forecast, By Application
5.2. Skin Soft Tissues Infections
  5.2.1. Key Market Trends, Growth Factors and Opportunities
  5.2.2. Market Size and Forecast, By Region
  5.2.3. Market Share Analysis, By Country
5.3. GI Tract Infections
  5.3.1. Key Market Trends, Growth Factors and Opportunities
  5.3.2. Market Size and Forecast, By Region
  5.3.3. Market Share Analysis, By Country
5.4. Sexually Transmitted Diseases
  5.4.1. Key Market Trends, Growth Factors and Opportunities
  5.4.2. Market Size and Forecast, By Region
  5.4.3. Market Share Analysis, By Country
5.5. Others
  5.5.1. Key Market Trends, Growth Factors and Opportunities
  5.5.2. Market Size and Forecast, By Region
  5.5.3. Market Share Analysis, By Country

CHAPTER 6: VIROLOGY MARKET, BY REGION

6.1. Market Overview
  6.1.1 Market Size and Forecast, By Region
6.2. North America
  6.2.1. Key Market Trends and Opportunities
  6.2.2. Market Size and Forecast, By Type
  6.2.3. Market Size and Forecast, By Application
  6.2.4. Market Size and Forecast, By Country
  6.2.5. U.S. Virology Market
    6.2.5.1. Market Size and Forecast, By Type
    6.2.5.2. Market Size and Forecast, By Application
  6.2.6. Canada Virology Market
    6.2.6.1. Market Size and Forecast, By Type
    6.2.6.2. Market Size and Forecast, By Application
  6.2.7. Mexico Virology Market
    6.2.7.1. Market Size and Forecast, By Type
    6.2.7.2. Market Size and Forecast, By Application
6.3. Europe
  6.3.1. Key Market Trends and Opportunities
  6.3.2. Market Size and Forecast, By Type
  6.3.3. Market Size and Forecast, By Application
  6.3.4. Market Size and Forecast, By Country
  6.3.5. France Virology Market
    6.3.5.1. Market Size and Forecast, By Type
    6.3.5.2. Market Size and Forecast, By Application
  6.3.6. Germany Virology Market
    6.3.6.1. Market Size and Forecast, By Type
    6.3.6.2. Market Size and Forecast, By Application
  6.3.7. Italy Virology Market
    6.3.7.1. Market Size and Forecast, By Type
    6.3.7.2. Market Size and Forecast, By Application
  6.3.8. Spain Virology Market
    6.3.8.1. Market Size and Forecast, By Type
    6.3.8.2. Market Size and Forecast, By Application
  6.3.9. UK Virology Market
    6.3.9.1. Market Size and Forecast, By Type
    6.3.9.2. Market Size and Forecast, By Application
  6.3.10. Rest Of Europe Virology Market
    6.3.10.1. Market Size and Forecast, By Type
    6.3.10.2. Market Size and Forecast, By Application
6.4. Asia-Pacific
  6.4.1. Key Market Trends and Opportunities
  6.4.2. Market Size and Forecast, By Type
  6.4.3. Market Size and Forecast, By Application
  6.4.4. Market Size and Forecast, By Country
  6.4.5. China Virology Market
    6.4.5.1. Market Size and Forecast, By Type
    6.4.5.2. Market Size and Forecast, By Application
  6.4.6. Japan Virology Market
    6.4.6.1. Market Size and Forecast, By Type
    6.4.6.2. Market Size and Forecast, By Application
  6.4.7. India Virology Market
    6.4.7.1. Market Size and Forecast, By Type
    6.4.7.2. Market Size and Forecast, By Application
  6.4.8. South Korea Virology Market
    6.4.8.1. Market Size and Forecast, By Type
    6.4.8.2. Market Size and Forecast, By Application
  6.4.9. Australia Virology Market
    6.4.9.1. Market Size and Forecast, By Type
    6.4.9.2. Market Size and Forecast, By Application
  6.4.10. Rest of Asia-Pacific Virology Market
    6.4.10.1. Market Size and Forecast, By Type
    6.4.10.2. Market Size and Forecast, By Application
6.5. LAMEA
  6.5.1. Key Market Trends and Opportunities
  6.5.2. Market Size and Forecast, By Type
  6.5.3. Market Size and Forecast, By Application
  6.5.4. Market Size and Forecast, By Country
  6.5.5. Brazil Virology Market
    6.5.5.1. Market Size and Forecast, By Type
    6.5.5.2. Market Size and Forecast, By Application
  6.5.6. South Africa Virology Market
    6.5.6.1. Market Size and Forecast, By Type
    6.5.6.2. Market Size and Forecast, By Application
  6.5.7. Saudi Arabia Virology Market
    6.5.7.1. Market Size and Forecast, By Type
    6.5.7.2. Market Size and Forecast, By Application
  6.5.8. UAE Virology Market
    6.5.8.1. Market Size and Forecast, By Type
    6.5.8.2. Market Size and Forecast, By Application
  6.5.9. Rest of LAMEA Virology Market
    6.5.9.1. Market Size and Forecast, By Type
    6.5.9.2. Market Size and Forecast, By Application

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

8.1. GlaxoSmithKline Plc.
  8.1.1. Company Overview
  8.1.2. Key Executives
  8.1.3. Company Snapshot
  8.1.4. Operating Business Segments
  8.1.5. Product Portfolio
  8.1.6. Business Performance
  8.1.7. Key Strategic Moves and Developments
8.2. Abbott Laboratories
  8.2.1. Company Overview
  8.2.2. Key Executives
  8.2.3. Company Snapshot
  8.2.4. Operating Business Segments
  8.2.5. Product Portfolio
  8.2.6. Business Performance
  8.2.7. Key Strategic Moves and Developments
8.3. Boehringer Ingelheim Corporation
  8.3.1. Company Overview
  8.3.2. Key Executives
  8.3.3. Company Snapshot
  8.3.4. Operating Business Segments
  8.3.5. Product Portfolio
  8.3.6. Business Performance
  8.3.7. Key Strategic Moves and Developments
8.4. Merck And Co. Inc.
  8.4.1. Company Overview
  8.4.2. Key Executives
  8.4.3. Company Snapshot
  8.4.4. Operating Business Segments
  8.4.5. Product Portfolio
  8.4.6. Business Performance
  8.4.7. Key Strategic Moves and Developments
8.5. Novartis International Ag
  8.5.1. Company Overview
  8.5.2. Key Executives
  8.5.3. Company Snapshot
  8.5.4. Operating Business Segments
  8.5.5. Product Portfolio
  8.5.6. Business Performance
  8.5.7. Key Strategic Moves and Developments
8.6. Siemens
  8.6.1. Company Overview
  8.6.2. Key Executives
  8.6.3. Company Snapshot
  8.6.4. Operating Business Segments
  8.6.5. Product Portfolio
  8.6.6. Business Performance
  8.6.7. Key Strategic Moves and Developments
8.7. Johnson And Johnson
  8.7.1. Company Overview
  8.7.2. Key Executives
  8.7.3. Company Snapshot
  8.7.4. Operating Business Segments
  8.7.5. Product Portfolio
  8.7.6. Business Performance
  8.7.7. Key Strategic Moves and Developments
8.8. AstraZeneca AB
  8.8.1. Company Overview
  8.8.2. Key Executives
  8.8.3. Company Snapshot
  8.8.4. Operating Business Segments
  8.8.5. Product Portfolio
  8.8.6. Business Performance
  8.8.7. Key Strategic Moves and Developments
8.9. Roche
  8.9.1. Company Overview
  8.9.2. Key Executives
  8.9.3. Company Snapshot
  8.9.4. Operating Business Segments
  8.9.5. Product Portfolio
  8.9.6. Business Performance
  8.9.7. Key Strategic Moves and Developments
8.10. Trinity Biotech
  8.10.1. Company Overview
  8.10.2. Key Executives
  8.10.3. Company Snapshot
  8.10.4. Operating Business Segments
  8.10.5. Product Portfolio
  8.10.6. Business Performance
  8.10.7. Key Strategic Moves and Developments